Home > General Medicines > COPD Treatment

COPD Treatment in Mumbai

Managing Breathlessness, Protecting Lung Function, and Reducing Exacerbations

Chronic Obstructive Pulmonary Disease is a progressive lung condition - but progression is not inevitable when the right management is in place from the right time. COPD treatment in Mumbai at Shree Hospitals provides comprehensive chronic obstructive pulmonary disease management for breathlessness and exacerbations through an experienced pulmonology team. From spirometry-confirmed diagnosis and inhaler therapy optimisation to structured bronchodilator and pulmonary rehabilitation for COPD patients, our programme is built around maximising lung function, minimising exacerbation frequency, and improving the daily quality of life of every patient living with this challenging condition.

What is COPD Treatment?

Chronic Obstructive Pulmonary Disease is a preventable and treatable lung disease characterised by persistent respiratory symptoms and irreversible airflow limitation caused by airway and alveolar damage - most commonly from long-term tobacco smoke exposure, though occupational dust, biomass fuel smoke, and recurrent childhood respiratory infections also contribute significantly in the Indian context.
 

Chronic obstructive pulmonary disease management for breathlessness and exacerbations at Shree Hospitals begins with spirometry-confirmed diagnosis - a post-bronchodilator FEV1/FVC ratio below 0.70 is the diagnostic standard - followed by GOLD severity staging, assessment of symptom burden using the CAT or mMRC dyspnoea scale, and exacerbation history to determine which ABCD treatment group the patient belongs to. COPD inhaler therapy is the foundation of management - short-acting bronchodilators for symptom relief, and long-acting bronchodilators (LABA, LAMA, or combined LABA/LAMA) as maintenance therapy. Inhaled corticosteroid-containing combinations are added for patients with frequent exacerbations and blood eosinophilia. COPD exacerbation management - acute worsening of respiratory symptoms requiring treatment change - is managed with systemic corticosteroids, antibiotics for infective exacerbations, nebulized bronchodilators, oxygen therapy, and if necessary non-invasive ventilation.

 
Bronchodilator and pulmonary rehabilitation for COPD patients through a structured exercise, education, and breathing technique programme significantly improves exercise capacity, dyspnoea, and quality of life - with evidence of benefit exceeding any pharmacological intervention currently available for COPD.

When Should COPD Be Suspected and Investigated?

• Persistent breathlessness on exertion in a current or ex-smoker above 40 years
• Chronic productive cough lasting more than 3 months in 2 consecutive years
• Recurrent chest infections requiring antibiotics - particularly in winter months
• Wheeze and chest tightness not responding adequately to bronchodilator therapy
• Significant occupational or biomass smoke exposure with unexplained breathlessness

How is COPD Severity Assessed?

• Spirometry diagnosis - post-bronchodilator FEV1/FVC below 0.70 confirms airflow obstruction
• FEV1 percentage predicted determines GOLD severity grade 1 to 4
• CAT questionnaire - 8-item symptom assessment tool quantifying COPD impact on daily life
• mMRC dyspnoea scale - 0 to 4 grading of breathlessness at different activity levels
• Exacerbation history - number of exacerbations in the previous year determines treatment group

24×7 Emergency Care

Our Approach to COPD Treatment

At Shree Hospitals, COPD treatment in Mumbai follows current GOLD guideline recommendations - with every patient assessed using spirometry, symptom questionnaires, and exacerbation history before any treatment decision is made. Our pulmonology team selects the most appropriate inhaler combination for each patient's GOLD group - and addresses smoking cessation, inhaler technique, vaccination, and rehabilitation as essential components of every COPD management plan.

Spirometry-Based Diagnosis and GOLD Staging

Every patient with suspected COPD undergoes post-bronchodilator spirometry in our pulmonary function laboratory. FEV1, FVC, FEV1/FVC ratio, and flow-volume loop morphology are reviewed by the pulmonologist. Spirometry diagnosis confirms airflow limitation, quantifies severity, and distinguishes COPD from asthma - critical for selecting the correct treatment pathway from the outset.

Inhaler Therapy Optimisation

Inhaler choice and technique are optimised at every appointment. Short-acting bronchodilators (salbutamol, ipratropium) are prescribed for rescue use. Long-acting LAMA therapy - tiotropium or umeclidinium - is the preferred maintenance treatment for GOLD B and C patients. LABA/LAMA combinations are used for patients with persistent dyspnoea. ICS is added only for patients with frequent exacerbations and elevated blood eosinophil count.

Exacerbation Prevention and Management

COPD exacerbation management prevention includes vaccination - annual influenza and pneumococcal - optimised maintenance inhaler therapy, and early patient education on recognising and responding to exacerbations. When exacerbations occur, systemic prednisolone for 5 days, antibiotics for infective episodes, and intensified nebulized bronchodilator therapy are initiated promptly to minimise hospitalisation duration and prevent FEV1 decline.

Pulmonology and Respiratory Services at Shree Hospitals

Patient
Resources